Drug class in one race
LRRK2 drugs for Parkinson's Disease
2 tracked LRRK2 drugs in the Parkinson's Disease race. The class explanation lives on the LRRK2 page; the full indication pipeline across every mechanism is on the Parkinson's Disease page.
1 Phase 31 preclinical / unstaged
Head-to-head evidence: BIIB122 / DNL151 (LRRK2 inhibitor) vs NEU-411